Logo image of CPR.MI

DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis

BIT:CPR - Euronext Milan - NL0015435975 - Common Stock - Currency: EUR

5.61  -0.06 (-1.06%)

Fundamental Rating

3

Taking everything into account, CPR scores 3 out of 10 in our fundamental rating. CPR was compared to 25 industry peers in the Beverages industry. Both the profitability and the financial health of CPR get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, CPR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CPR was profitable.
In the past year CPR had a positive cash flow from operations.
Each year in the past 5 years CPR has been profitable.
In the past 5 years CPR always reported a positive cash flow from operatings.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

CPR's Return On Assets of 2.38% is on the low side compared to the rest of the industry. CPR is outperformed by 60.00% of its industry peers.
CPR's Return On Equity of 5.23% is on the low side compared to the rest of the industry. CPR is outperformed by 64.00% of its industry peers.
CPR has a Return On Invested Capital of 6.63%. This is comparable to the rest of the industry: CPR outperforms 52.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CPR is in line with the industry average of 7.98%.
Industry RankSector Rank
ROA 2.38%
ROE 5.23%
ROIC 6.63%
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 6.57%, CPR perfoms like the industry average, outperforming 44.00% of the companies in the same industry.
In the last couple of years the Profit Margin of CPR has declined.
CPR has a Operating Margin of 21.32%. This is in the better half of the industry: CPR outperforms 64.00% of its industry peers.
In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
The Gross Margin of CPR (57.55%) is better than 72.00% of its industry peers.
CPR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.32%
PM (TTM) 6.57%
GM 57.55%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CPR is still creating some value.
Compared to 1 year ago, CPR has more shares outstanding
CPR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CPR has remained at the same level compared to a year ago.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CPR has an Altman-Z score of 2.40. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.40, CPR is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
The Debt to FCF ratio of CPR is 13.61, which is on the high side as it means it would take CPR, 13.61 years of fcf income to pay off all of its debts.
CPR's Debt to FCF ratio of 13.61 is on the low side compared to the rest of the industry. CPR is outperformed by 64.00% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that CPR is somewhat dependend on debt financing.
CPR has a better Debt to Equity ratio (0.66) than 72.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 13.61
Altman-Z 2.4
ROIC/WACC0.95
WACC6.96%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

CPR has a Current Ratio of 2.37. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CPR (2.37) is better than 84.00% of its industry peers.
A Quick Ratio of 0.99 indicates that CPR may have some problems paying its short term obligations.
CPR has a Quick ratio of 0.99. This is amongst the best in the industry. CPR outperforms 92.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 0.99
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

The earnings per share for CPR have decreased strongly by -39.43% in the last year.
CPR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.12% yearly.
Looking at the last year, CPR shows a small growth in Revenue. The Revenue has grown by 5.18% in the last year.
CPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.75% yearly.
EPS 1Y (TTM)-39.43%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-109.15%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%-45.74%

3.2 Future

Based on estimates for the next years, CPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.99% on average per year.
CPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.57% yearly.
EPS Next Y1.31%
EPS Next 2Y6.65%
EPS Next 3Y8.05%
EPS Next 5Y9.99%
Revenue Next Year5.14%
Revenue Next 2Y5.03%
Revenue Next 3Y5.27%
Revenue Next 5Y5.57%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 31.17, which means the current valuation is very expensive for CPR.
Compared to the rest of the industry, the Price/Earnings ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 68.00% of the companies listed in the same industry.
CPR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.32, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 18.65, CPR is valued on the expensive side.
64.00% of the companies in the same industry are cheaper than CPR, based on the Price/Forward Earnings ratio.
CPR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.17
Fwd PE 18.65
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CPR is valued a bit more expensive than the industry average as 64.00% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, CPR is valued a bit more expensive than the industry average as 64.00% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 32.83
EV/EBITDA 12.54
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)23.8
PEG (5Y)N/A
EPS Next 2Y6.65%
EPS Next 3Y8.05%

2

5. Dividend

5.1 Amount

CPR has a Yearly Dividend Yield of 1.11%. Purely for dividend investing, there may be better candidates out there.
With a Dividend Yield of 1.11, CPR pays less dividend than the industry average, which is at 2.89. 84.00% of the companies listed in the same industry pay a better dividend than CPR!
With a Dividend Yield of 1.11, CPR pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.11%

5.2 History

The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CPR pays out 38.74% of its income as dividend. This is a sustainable payout ratio.
DP38.74%
EPS Next 2Y6.65%
EPS Next 3Y8.05%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

DAVIDE CAMPARI-MILANO NV

BIT:CPR (6/18/2025, 5:35:15 PM)

5.61

-0.06 (-1.06%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)05-08 2025-05-08
Earnings (Next)07-31 2025-07-31
Inst Owners21.06%
Inst Owner ChangeN/A
Ins Owners52%
Ins Owner ChangeN/A
Market Cap6.91B
Analysts70.37
Price Target7.04 (25.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.11%
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.74%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.82%
PT rev (3m)-11.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-5.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.93%
Valuation
Industry RankSector Rank
PE 31.17
Fwd PE 18.65
P/S 2.25
P/FCF 32.83
P/OCF 10.3
P/B 1.79
P/tB 151.48
EV/EBITDA 12.54
EPS(TTM)0.18
EY3.21%
EPS(NY)0.3
Fwd EY5.36%
FCF(TTM)0.17
FCFY3.05%
OCF(TTM)0.54
OCFY9.71%
SpS2.49
BVpS3.13
TBVpS0.04
PEG (NY)23.8
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.38%
ROE 5.23%
ROCE 9.04%
ROIC 6.63%
ROICexc 6.65%
ROICexgc 14.08%
OM 21.32%
PM (TTM) 6.57%
GM 57.55%
FCFM 6.85%
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexcg growth 3Y-20.45%
ROICexcg growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 13.61
Debt/EBITDA 3.27
Cap/Depr 360.3%
Cap/Sales 14.99%
Interest Coverage 6.98
Cash Conversion 85.73%
Profit Quality 104.37%
Current Ratio 2.37
Quick Ratio 0.99
Altman-Z 2.4
F-Score4
WACC6.96%
ROIC/WACC0.95
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.43%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-109.15%
EPS Next Y1.31%
EPS Next 2Y6.65%
EPS Next 3Y8.05%
EPS Next 5Y9.99%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%-45.74%
Revenue Next Year5.14%
Revenue Next 2Y5.03%
Revenue Next 3Y5.27%
Revenue Next 5Y5.57%
EBIT growth 1Y6.39%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year23.05%
EBIT Next 3Y13.08%
EBIT Next 5Y11.08%
FCF growth 1Y232.49%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y328.44%
OCF growth 3Y11.5%
OCF growth 5Y13.06%